Christopher D. Turner's Insider Trades & SAST Disclosures

Christopher D. Turner's most recent trade in Nuvalent Inc - Ordinary Shares - Class A was a trade of 37,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 6, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 37,500 37,500 - - Stock Option (Right to Buy)
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2025 18,750 66,563 - 0 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Sale of securities on an exchange or to another person at price $ 80.54 per share. 06 Jan 2025 2,173 62,547 - 80.5 175,013 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Sale of securities on an exchange or to another person at price $ 78.28 per share. 06 Jan 2025 1,152 65,411 - 78.3 90,179 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Sale of securities on an exchange or to another person at price $ 79.33 per share. 06 Jan 2025 691 64,720 - 79.3 54,817 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Turner D. Christopher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 47,500 47,500 - - Stock Option (Right to Buy)
Nuvalent Inc - Ordinary Sh...
D. Turner Christopher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 33,300 47,813 - 0 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jul 2023 2,665 311,100 - - Stock Option (Right to Buy)
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Sale of securities on an exchange or to another person at price $ 48.93 per share. 26 Jul 2023 2,665 14,513 - 48.9 130,398 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. 26 Jul 2023 2,665 17,178 - 6.9 18,362 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Sale of securities on an exchange or to another person at price $ 46.85 per share. 26 Jul 2023 2,365 14,513 - 46.8 110,800 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jul 2023 2,365 313,765 - - Stock Option (Right to Buy)
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. 26 Jul 2023 2,365 16,878 - 6.9 16,295 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jul 2023 200 316,130 - - Stock Option (Right to Buy)
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Sale of securities on an exchange or to another person at price $ 46.82 per share. 20 Jul 2023 200 14,513 - 46.8 9,364 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. 20 Jul 2023 200 14,713 - 6.9 1,378 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Sale of securities on an exchange or to another person at price $ 46.80 per share. 20 Jul 2023 100 14,513 - 46.8 4,680 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jul 2023 100 316,330 - - Stock Option (Right to Buy)
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. 20 Jul 2023 100 14,613 - 6.9 689 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. 05 Jun 2023 10,235 24,748 - 6.9 70,519 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Sale of securities on an exchange or to another person at price $ 44.86 per share. 05 Jun 2023 10,235 14,513 - 44.9 459,142 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jun 2023 10,235 316,430 - - Stock Option (Right to Buy)
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2023 144,200 144,200 - - Stock Option (Right to Buy)
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. 17 May 2022 14,513 14,513 - 6.9 99,995 Class A Common Stock
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 May 2022 14,513 326,665 - - Stock Option (Right to Buy)
Nuvalent Inc - Ordinary Sh...
Christopher D. Turner Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2022 107,000 107,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades